MYGN icon

Myriad Genetics
MYGN

Overview Fund Activity

228 hedge funds and large institutions have $833M invested in Myriad Genetics in 2025 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 79 increasing their positions, 77 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
228
Holders Change
+9
Holders Change %
+4.11%
% of All Funds
3.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
40
Increased
79
Reduced
77
Closed
28
Calls
$854K
Puts
$170K
Net Calls
+$684K
Net Calls Change
-$3.13M

Top Buyers

1
DGI
Disciplined Growth Investors
Minnesota
+$19.3M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$6.91M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$6.23M
4
PCM
Portolan Capital Management
Massachusetts
+$4.88M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
+$3.75M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$12.5M
2
CCM
Camber Capital Management
Massachusetts
-$6.65M
3
PCM
Peregrine Capital Management
Minnesota
-$4.7M
4
Artisan Partners
Artisan Partners
Wisconsin
-$4.34M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$4.14M
Name Holding Trade Value Shares
Change 		Shares
Change %
DPW
251
DiNuzzo Private Wealth
Pennsylvania
– -$42 -3 Closed
SIC
252
SJS Investment Consulting
Ohio
– -$28 -2 Closed
PWM
253
Parkworth Wealth Management
California
– -$14 -1 Closed
7 8 9 10
11